235 related articles for article (PubMed ID: 7583391)
1. Long-term central venous access in patients with sickle cell disease. Incidence of thrombotic and infectious complications.
Abdul-Rauf A; Gauderer M; Chiarucci K; Berman B
J Pediatr Hematol Oncol; 1995 Nov; 17(4):342-5. PubMed ID: 7583391
[TBL] [Abstract][Full Text] [Related]
2. Cathlink 20: a subcutaneous implanted central venous access device used in children with sickle cell disease on long-term erythrocytapheresis--a report of low complication rates.
Raj A; Bertolone S; Bond S; Burnett D; Denker A
Pediatr Blood Cancer; 2005 Jun; 44(7):669-72. PubMed ID: 15700248
[TBL] [Abstract][Full Text] [Related]
3. Use of infusion ports in patients with sickle cell disease: Indications and complications.
Ilonze C; Anderson M; Stubblefield A; Journeycake J; Sinha AA
Pediatr Blood Cancer; 2022 Feb; 69(2):e29445. PubMed ID: 34786823
[TBL] [Abstract][Full Text] [Related]
4. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
[TBL] [Abstract][Full Text] [Related]
5. Portacaths are safe for long-term regular blood transfusion in children with sickle cell anaemia.
Bartram JL; O'Driscoll S; Kulasekararaj AG; Height SE; Dick M; Patel S; Rees DC
Arch Dis Child; 2011 Nov; 96(11):1082-4. PubMed ID: 20605863
[TBL] [Abstract][Full Text] [Related]
6. Complications of Central Venous Access Devices in Patients With Sickle Cell Disease and Thalassemia Major.
Ordóñez J; Del Cañizo A; Beléndez C; García-Morín M; Pérez-Egido L; Fanjul M; García-Casillas MA; Cerdá J; Peláez D; Bardón E; de Agustín JC; Cela E
J Pediatr Hematol Oncol; 2021 Jul; 43(5):e655-e660. PubMed ID: 33093353
[TBL] [Abstract][Full Text] [Related]
7. Complications of implantable venous access devices in patients with sickle cell disease.
Shah N; Landi D; Shah R; Rothman J; De Castro LM; Thornburg CD
Am J Hematol; 2012 Feb; 87(2):224-6. PubMed ID: 22081438
[TBL] [Abstract][Full Text] [Related]
8. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
[TBL] [Abstract][Full Text] [Related]
9. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
[TBL] [Abstract][Full Text] [Related]
10. Infectious morbidity associated with long-term use of venous access devices in patients with cancer.
Groeger JS; Lucas AB; Thaler HT; Friedlander-Klar H; Brown AE; Kiehn TE; Armstrong D
Ann Intern Med; 1993 Dec; 119(12):1168-74. PubMed ID: 8239247
[TBL] [Abstract][Full Text] [Related]
11. Central venous catheter complications in sickle cell disease.
Jeng MR; Feusner J; Skibola C; Vichinsky E
Am J Hematol; 2002 Feb; 69(2):103-8. PubMed ID: 11835345
[TBL] [Abstract][Full Text] [Related]
12. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome.
McMahon C; Smith J; Khair K; Liesner R; Hann IM; Smith OP
Br J Haematol; 2000 Aug; 110(2):461-8. PubMed ID: 10971409
[TBL] [Abstract][Full Text] [Related]
13. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of infectious complications associated with central venous access devices in children with haemophilia.
Tarantino MD; Lail A; Donfield SM; Lynn H; Peddle L; Hunsberger S; Shapiro AD
Haemophilia; 2003 Sep; 9(5):588-92. PubMed ID: 14511299
[TBL] [Abstract][Full Text] [Related]
15. Totally implantable intravenous catheters in the management of sickle cell anemia.
Phillips G; Slingluff C; Hartman J; Thomas P; Akwari O
Am J Hematol; 1988 Nov; 29(3):134-8. PubMed ID: 3189307
[TBL] [Abstract][Full Text] [Related]
16. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.
Bedoya MA; Raffini L; Durand R; Acord MR; Srinivasan A; Krishnamurthy G; Vatsky S; Escobar F; Cahill AM
Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060
[TBL] [Abstract][Full Text] [Related]
17. Use of a dual lumen port for automated red cell exchange in adults with sickle cell disease.
Shrestha A; Jawa Z; Koch KL; Rankin AB; Xiang Q; Padmanabhan A; Karafin MS; Field JJ
J Clin Apher; 2015 Dec; 30(6):353-8. PubMed ID: 25790325
[TBL] [Abstract][Full Text] [Related]
18. Traditional Long-Term Central Venous Catheters Versus Transhepatic Venous Catheters in Infants and Young Children.
Marshall AM; Danford DA; Curzon CL; Anderson V; Delaney JW
Pediatr Crit Care Med; 2017 Oct; 18(10):944-948. PubMed ID: 28746169
[TBL] [Abstract][Full Text] [Related]
19. Complications of indwelling catheters in cystic fibrosis: a 10-year review.
Aitken ML; Tonelli MR
Chest; 2000 Dec; 118(6):1598-602. PubMed ID: 11115445
[TBL] [Abstract][Full Text] [Related]
20. Infection rates of Broviac-Hickman catheters and implantable venous devices.
Wurzel CL; Halom K; Feldman JG; Rubin LG
Am J Dis Child; 1988 May; 142(5):536-40. PubMed ID: 3358396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
